Atlas Trials

A Pilot Study of Metformin Treatment in Patients With Well-differentiated Neuroendocrine Tumors

Clinical trial NCT02279758 · UNKNOWN

Trial details

NCT number
NCT02279758
Sponsor
Instituto do Cancer do Estado de São Paulo
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Well-differentiated Neuroendocrine Tumors
Start date
2014-03-01
Primary completion
2017-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.